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ABSTRACT 
Dithiocarbamates are a class of sulfur-based metal-chelating compounds with various applications in medicine. A new series of new transition 
metal [Cu(II), and Ni(II)] complexes of dithiocarbamates were synthesized from 2-Amino-3-Methyl pyridine and Carbon disulfide and further 
characterized. The investigation of these complexes confirmed that the stability of metal–ligands coordination through, S&S,N atoms as 
bidendate chelates.. It is necessary to understand the binding properties in developing new potential Protein targeting against neurological 
disorders. 
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INTRODUCTION 
The field of Dithiocarbamate metal complexes are vast and 
fast developing on account of their spectacular applications 
in various fields, also owing to the varieties of structural 
forms of the ligands. The ever-increasing applications of 
transition metal complexes in different fields of sciences are 
the driving force for the present research[1].The 
Dithiocarbamates are organosulphur compounds considered 
to be versatile organic ligands which form complexes with 
many transition metals like Cu, Fe, Ni, Mn and Zn leading to 
the stabilization of a wide range of oxidation states. 
The complexing ability of dithiocarbamates is well 
established and this is due to two sulphur atoms, which are 
capable to donate a lone pair of electrons to the central 
metal atom to form the stable metal complexes[2]. These are 
known to stabilize unusual oxidation states of metal 
complexes, because of the delocalization of positive charge 
from the metal to nitrogen. Besides, dithiocarbamates ligand 
and its metal complexes exhibit their striking and diversified 
applications in many fields like Medicine, Agriculture 
Industry, Polymer technology, Inorganic and Environmental 
trace analysis[3]. 
Dithiocarbamates ligands are soft bases. They had been 
found to act almost as uni negative bidentate ligands 
coordinating through sulphur atoms, and also both tetra and 
hexa co-ordinate complex of many transitional metal ions 
have been isolated[4-6]. They exhibit various applications in 
different fields especially in the production of petroleum 
derivatives, lubricants, as accelerators for vulcanization in 
Polymer Industry, as antioxidants and anti humidity agents. 
They are also having fungicidal, bactericidal, insecticidal, 
anticancer, and photochemical activities. Dithiocarbamates 
ligands itself acts as a good antibacterial and antifungal 
activity and are used as biocides (vapam, nabam)[6-10]. 
Owing to wide applicability of sulphur bearing ligands in 
biological and industrial field, a bulk of literature is available 
on the dithiocarbamates ligands and its complexes of 
transition and non-transition metals. A large number of 
transition metal complexes with various aliphatic and 
aromatic dithiocarbamate ligands have been reported. 
Though a number of dithiocarbamates have been prepared 
in the literature. 
2-Amino3-Methyl pyridine dithiocarbamate is a dopamine 
agonist. Treating the signs and symptoms of Parkinson 
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disease. It is also used to treat restless legs syndrome (RLS). 
Pramipexole is used to treat symptoms of Parkinson's 
disease (stiffness, tremors, muscle spasms, and poor muscle 
control). Pramipexole is also used to treat restless legs 
syndrome (RLS).Only immediate-release pramipexole 
(Mirapex) is approved to treat either Parkinson symptoms 
or RLS. Extended-release pramipexole (Mirapex ER) is 
approved only to treat Parkinson symptoms. 
Insights gained from decades of research have begun to 
unlock the pathophysiology of these complex diseases and 
have provided targets for disease-modifying therapies. In 
the last decade, few therapeutic agents designed to modify 
the underlying disease process have progressed to clinical 
trials and none have been brought to market. With the focus 
on disease modification, biomarkers promise to play an 
increasingly important role in clinical trials. Among the 
histamine receptor subtypes, H3 receptors play an 
important regulatory role in the CNS. Activation of H3 auto 
receptors can inhibit histamine synthesis and release from 
histaminergic neurons, while activation of H3 hetero 
receptors can inhibit release of other neurotransmitters 
such acetylcholine, noradrenaline, dopamine and 5-HT from 
non-histaminergic neurons. Conversely, blockade of H3 
receptors with selective antagonists can increase the release 
of neurotransmitters involved in cognitive processes. 
Selective H3 receptor antagonists have been shown to 
improve performance in a diverse range of rodent cognition 
paradigms, and can also increase wakefulness. This has led 
to the development of H3receptor antagonists for the 
potential treatment of several CNS disorders including 
cognitive dysfunction in Alzheimer’s disease (AD).  
Parkinson's disease (PD) is one of the most common 
diseases of the central nervous system (CNS). It is frequently 
heralded by speech disturbances, which are one of its first 
symptoms. Parkinson’s disease (PD) is a progressive extra 
pyramidal motor disorder. Pathologically, this disease is 
characterized by the selective dopaminergic (DAergic) 
neuronal degeneration in the Substantia nigra. Correcting 
the DA deficiency in PD with levodopa (Ldopa) significantly 
attenuates the motor symptoms; however, its effectiveness 
often declines, and L-dopa-related adverse effects emerge 
after long-term treatment. Nowadays, DA receptor agonists  
are useful medication even regarded as first choice to delay 
the starting of L-dopa therapy. In advanced stage of PD, they 
are also used as adjunct therapy together with L-dopa. DA 
receptor agonists act by stimulation of presynaptic and 
postsynaptic DA receptors. Despite the usefulness, they 
could be causative drugs for valvulopathy and nonmotor 
complication such as DA dysregulation syndrome (DDS).It is 
necessary to understand the binding properties in 
developing new potential Protein targeting against 
neurological disorders. 
The present work has been extended to know antibacterial 
activity, anti inflammatory activity and antifungal activity of 
the dithiocarbamates metal complexes.   
The main thrust of the study is to prepare as such new 
dithiocarbamates ligand from an amine having considerable 
amount of applications on its own with the hope that the 
resultant dithiocarbamates may possess much more 
applications and find a place in major fields of interest. 
MATERIALS AND METHODS 
Experimental Section 
Copper chloride anhydrous was obtained from Fluka, 
Pramipexole and carbon disulfide were purchased from 
Aldrich. Other chemicals used were of analytical reagent or 
higher purity grade. Solvents used were of reagent grade 
and purified before use by the standard methods. 
Conductivity measurement was carried out by a Systronics 
Conductivity Bridge 305, using a conductivity cell of cell 
constant 1.0 double distilled water was used as solvent. 
Electronic absorption spectra on JAS.CO UV/VIS-7850 
recording spectrophotometer. Infrared spectra were 
recorded on a JAS.Co-460 plus FT-IR spectrophotometer in 
the range of 4000-400 cm-1 in KBr pellets. Microchemical 
analysis of carbon, hydrogen and nitrogen for the complexes 
were carried out on a Herause CHNO-Rapid elemental 
analyzer.1H NMR spectra were recorded on a Brucker DRX-
500 Advance spectrometer at 500MHz in DMSO-discussing 
tetramethylsilane as internal reference standard. Melting 
points were measured on a unimelt capillary melting Point 
apparatus and reported uncorrected. 
Synthesis of 2-Amino-3-Methyl pyridine 
dithiocarbamate 
 
 
 
 
 
Preparation of Sodium salt of Dithiocarbamate ligands 
0.05 mol of 2-Amino-3-Methyl pyridine was dissolved in 30 
ml of absolute alcohol in a clean beaker which was placed in 
ice bath. To this cold solution add 5 ml of Sodium hydroxide 
(10N) solution, and then add Pure carbon disulphide 
(0.05ml) in drop wise with constant stirring. The contents 
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were stirred mechanically for about 30 min, sodium salt of 
dithiocarbamates precipitated out. It was dried over and 
recrystallized from ethanol. 
Preparation of Cu (II) andNi (II) Complexes 
Synthesis of [Cu (ADTC)2)Cl2] 
The aqueous solution of 0.05 mol of Cupper Chloride was 
added with constant stirring to an aqueous solution of 0.01 
mol of Sodium salt of 2-Amino-3-Methyl pyridine 
dithiocarbamate ligand. The reaction mixture was stirred at 
room temperature for 2 hours. The colored (Blue) 
precipitates were obtained. The precipitates were filtered 
and washed with water and then with methanol and dried 
over calcium chloride in desiccator’s Yield: 78% and 
decomposes at 110 C. 
Anal.Calcd.C16H24CuS4N4O2;ForC,38.73;H,4.88;N,11.29;C
u,12.81;O,6.45,S,25.85;          
Found:C,38.78;H,4.93;N,11.32;Cu,12.94;O,6.50,S,25.90 
Synthesis of [Ni (ADTC)Cl2] 
The aqueous solution of 0.05 mol of Nickel Chloride was 
added with constant stirring to an aqueous solution of 0.01 
mol of Sodium salt of 2-Amino-3-Methyl pyridine 
dithiocarbamate in the presence of small quantity of 
triethylamine. The reaction mixture was stirred at room 
temperature for 2 hours. The colored (green) precipitates 
were obtained. The precipitates were filtered and washed 
with water and then with methanol and dried over calcium 
chloride in a desiccator Yield:80% and decomposes at 1100C.  
Anal.  Calcd. C16H24NiS4N4O2 For C, 39.11;   H, 4.92; N, 
11.40; O, 6.51; S, 26.10; Ni, 11.95 Found: C:39,16; H:4.97; 
N:11.40; O, 6.56; S:26.15; Ni, 11.98 
RESULTS AND DISCUSSION 
Solid reflectance spectra data for the Cu and Ni of 2-Amino-
3-Methyl pyridine metal complexes. The complexes 
[Cu(ADTC)2)Cl2] and [Ni(ADTC)2Cl2] complexes exhibit 
magnetic property and has an electronic spectrum which can 
be assigned to low spin Cu(II) and Ni(II) in an Octahedral 
Environment. Intra ligand electronic transition in 
then…C…S…S and S…C…S chronophers of the 
dithiocarbamate moiety. Thus the peak at 646 nm and the 
shoulder at 499 summarized from 1A1g_1T1g and 1A1g_ 
1T2g transitions, respectively. The other lower peaks are 
probably charge-transfer in origin.  
Infrared Spectrum 
Two regions of the IR spectrum of the [Cu(ADTC)2)Cl2] and 
[Ni(ADTC)2Cl2] complex have proven valuable in arguments 
concerning the electronic and structural characteristics of 
this compound. The presence of the thiouride band between 
1496-1404 cm-1suggest a considerable double bond 
character in the C…N bond vibration of the S2C-NR2 group. 
The band present in the 967-1071cm-1 range is attributed to 
the prevailing contribution of (C…S) Vibrations in these 
ranges have been used defectively in differentiating between 
monodentate, bidentate dithiocarbamate ligands. The 
presence of only one strong band supports bidentate 
coordination of the dithio ligands, whereas a doublet is 
expected in the case of monodentate coordination. (C…S) 
and (C..N) Stretching frequencies fall in the 1047 cm-1 (1001 
cm-1 to 1490 cm-1 respectively for the free ligand). The 
methyl group in the complex, as medium strong bands in the 
2924 cm-1 range can be related to the asymmetric CH3 
stretching vibration. 
H1-NMR Spectra 
The NMR spectrum of the [Cu(ADTC)2)Cl2] and 
[Ni(ADTC)2Cl2] complexes showed at7.70 ppm, which may 
be assigned to the hydroxyl protons. The peak at 7.9-9.76 
attributed to NH protons of thiouraide nitrogens in both 
complexes. In other signals is also appeared in the region 
0.90,1.5,3.8 ppm.N 
Antimicrobial Activity 
Antimicrobial test was performed on four bacterias 
(Staphylococcus aureus, Bacillus subtilis, Escherichia coli, 
Pseudomonas aeruginosa,) and two fungi (Candida albicans 
and Candida tropicalis). The media used were prepared by 
dissolving separately 2g of nutrient broth powder and 38g of 
the Mueller-Hinton agar powder in250 ml and 1 L of 
deionized water, respectively. Two media were sterilized in 
an autoclave at 1210C for 15 minutes and then stored 
overnight in a refrigerator after cooling. Cultures of the 
microorganisms were prepared in sterile nutrient broth and 
incubated for 24 hours at 370C for the bacteria and 270Cfor 
the fungi.0.1 ml of each of the overnight cultures in sterile 
test tubes with caps were made up to 10 ml with 9.9 ml of 
sterile deionized water 
 
Growth inhibition zone in millimeter(mm) 
BACTERIA FUNGUS 
 Gram +Ve       Gram -Ve  
 S.aur B.subt E.coli P.aerug C.alb C.trop 
Cu(ADTC) 14 14 15 14 14 15 
Ni(ADTC) 12 14 14 13 16 15 
FLU   ------ ----- 15 15 
DMSO 12 14 15 16 ----- ---- 
 
To give 1:100 or 10-2 dilution of the microorganisms. The 
technique used for the study was agar-well diffusion. 
Solutions of concentration 10 mg/ml of the compounds were 
made in dimethyl sulphoxide (DMSO). DMSO was also used 
as the negative control. Positive controls for bacteria and 
fungi were discs of commercial antibiotics manufactured by 
Abtek Biological Limited and Fluconazole dissolved in DMSO. 
The discs were carefully placed on the inoculated media with 
the aid of sterile forceps. Plates inoculated with bacteria 
were incubated at 370C for 24 hours, and those inoculated 
with fungi were incubated at 270C for 72 hours. Afterwards, 
the zones of inhibition of microbial growth that appeared 
around the wells of the compounds were examined and the 
diameters measured and recorded in millimeters (mm). 
Antimicrobial activity of the Cu(II) and Ni(II) complexes was 
evaluated in vitro against Gram positive bacteria-
Staphylococcus aureusand Bacillus subtilis, Gram negative 
bacteria-Escherichia coli, Pseudomonas aeruginosa and fungi, 
Candida albicans, Candida tropicalis. The results for the 
complexes and commercial antibiotics used as positive 
controls are listed in (Table 1). 
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CONCLUSION 
Cu (II) and Ni(II) complexes of 2-Amino-3-Methyl pyridine 
dithiocarbamate ligand with have been synthesized and 
characterized. The ligand moiety exhibits a bidentate 
coordination mode in the Cu (II) and Ni (II) complexes. Solid 
reflectance spectra and magnetic data indicate that the 
complexes are Paramagnetic and Octahedral. The complexes 
show selective activity towards some of the test 
microorganisms. In this Study, we have docking studies of H3 
receptor model with dithiocarbamate ligand and metal 
complexes  having more favorable rank score, docking score 
and hydrogen bonding energy and the binding pocket of the 
H3 receptor. Activation of H3 hetero receptors can inhibit 
release of other neurotransmitters such acetylcholine, 
noradrenaline, dopamine, conversely blockade of H3 
receptors with our synthesized selective antagonists can 
increase the release of neurotransmitters involved in 
cognitive processes. The biological studies of 
dithiocarbamate ligand and metal complexes with H3 
receptor and detailed analyses of metal inhibitors, H3 
receptor interactions were done and the residues in binding 
responsible for binding to the inhibitors of metal substrates 
with high binding affinity were identified.  Hence we 
conclude that these dithiocarbamate ligands and metal 
complexes could be a potential anti Neurological disorders 
lead molecules for modulating the expression of H3 receptor 
in Parkinson's disease (PD) and Alzheimer’s disease (AD) 
supports for experimental testing.  
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